| Ytd | -84.69% | |
| 1y | -96.66% |
| Open | 1.86 | Prev Close | 1.84 | Low | 1.69 | High | 1.86 | Mkt Cap | 2.62M |
| Vol | 35.92K | Avg Vol | 1.30M | EPS | 8.16 | P/E | 0.22 | Forward P/E | N/A |
| Beta | 1.83 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.92 | 200-d Avg | 7.73 | 1yr Est | 0.00 |
NXTS News
As previously disclosed, MitoCareX's broad structural analysis identified a set of SLC transport
Following its broad structural analysis of the human SLC transport protein family, MitoCareX advance
Nexentis Technologies Inc. ("Nexentis"), (NASDAQ:NXTS) ("Nexentis" or the "Compa
MitoCareX Bio completes comprehensive SLC transport protein analysis to support discovery of small m
Nexentis Technologies Inc. (NASDAQ:NXTS) ("Nexentis" or the "Company"), a drug disco
Neve Yarak, Israel, June 29, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Ne
US stocks lower, Nasdaq falls 500 points. Dow down 0.04%, Nasdaq 1.91%, S&P 500 1.27%. Consumer
US stocks down as Dow falls 300 points, while S&P 500 and NASDAQ also decrease. Consumer staples
Nexentis stock surged on AI drug discovery news before falling after announcing a $2.9 million offer
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 poi
US stocks rise, Dow up over 200 points. Financial shares jump 0.9% while communication services stoc
Under this initiative, MitoCareX intends to combine two complementary and independently validated ca
MITOLINE ® -Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in
Nexentis Technologies Inc. (NASDAQ:NXTS) ("Nexentis" or the "Company"), a drug disco
Ness Ziona, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) ("Ne
Shares of La-Z-Boy Inc (NYSE: LZB) rose 19.6% in pre-market trading after reporting better-than-expe
HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open
Nexentis Technologies Inc. (NASDAQ:NXTS) ("Nexentis" or the "Company"), a drug disco
Ness Ziona, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) ("Nex
MITOLINE-Powered Platform Delivers Optimized Hit Molecule, Strengthening the Foundation for Future P
Nexentis Technologies Inc. (NASDAQ:NXTS), ("Nexentis" or the "Company"), a drug disc
Neve Yarak, Israel, May 05, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS), ("Ne
Nexentis Technologies (NASDAQ: NXTS - Get Free Report) and Scheid Vineyards (OTCMKTS:SVIN - Get Free
Visit Nexentis at: www. nexentistech. com Neve Yarak, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Nex